Table 5.
Treatment; sample number (n) | Control; sample number (n) | Total clinical effect rate | Model used | Therapeutic effects and actions | Refs. |
---|---|---|---|---|---|
Acupuncture; n = 25 | Mifepristone; n = 25 | T: 92.0% vs. 52.0% | Human study | Pain score↓, CA-125↓, recurrence rate↓ | [74] |
Moxibustion; n = 27 | Ibuprofen; n = 27 | Human study | VAS score↓, the days of dysmenorrhea↓ | [77] | |
Acupoint catgut implantation therapy; n = 36 | Acupuncture; n = 36 | T: 96.97% vs. 90.63% | Human study | PGF2α↓, VAS score↓ | [86] |
Electroacupuncture; n = 36 | Mifepristone; n = 36 | T: 94.4% vs. 91.7% | Human study | Pain score↓, CA-125↓, recurrence rate↓ | [90] |
Auricular acupuncture; n = 37 | Herbal decoction; n = 30 | T: 91.9% vs. 60.0% | Human study | β-EP↑, dysmenorrhea score↓ | [96] |
Note: T (total effect rate) = number of effective cases/total number of cases; effective case refers to the patients or animal models whose signs and symptoms were improved after treatment.